mechanism of glp 1 agonist Frontiers A schematic representation of the
Description
J., Ahmad N
A review of serious adverse events linked with GLP-1 agonists in type 2 diabetes mellitus and obesity treatment
[DOI] [PMC free article] [PubMed] [Google Scholar] 80.Cortes TM, Vasquez L, Serra MC, Robbins R, Stepanenko A, Brown K, Barrus H, Campos A, Espinoza SE, Musi N
The gastrointestinal adverse event profile of albiglutide, a long-acting GLP-1 receptor agonist, in type 2 diabetes [abstract]
